Hassard James 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Jun 24, 2021
Insider Transaction Report
Form 4
Hassard James
Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-06-22$89.22/sh−3,625$323,423→ 105,750 total
Footnotes (1)
- [F1]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.